We are live on ! Find out more
IRMD icon

iRadimed

54 hedge funds and large institutions have $54.7M invested in iRadimed in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

0.13% more ownership

Funds ownership: 23.85%23.99% (+0.13%)

16% less funds holding

Funds holding: 6454 (-10)

26% less capital invested

Capital invested by funds: $73.7M → $54.7M (-$19M)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
54
Holders Change
-10
Holders Change %
-15.63%
% of All Funds
1.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
24
Reduced
20
Closed
11
Calls
Puts
Net Calls
Net Calls Change

IRMD Hedge Fund Activity: Q2 2019 in Review

54 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2019, worth a combined $54.7M — down 26% from $73.7M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of IRMD and 2 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 24 added.

The largest buyer was Marshall Wace, adding an estimated $1.55M. The largest seller was Russell Investments Group, exiting entirely with an estimated $1.77M sold.

  • 54 institutional investors held iRadimed (IRMD) as of Q2 2019, down from 64 in Q1 2019.
  • Funds reported $54.7M of iRadimed stock for Q2 2019, down 26% quarter-over-quarter.
  • 2 funds opened new iRadimed positions in Q2 2019 and 11 closed out, a net change of -9 holders.
  • The largest iRadimed buyer in Q2 2019 was Marshall Wace, an estimated $1.55M added.
  • The largest iRadimed seller in Q2 2019 was Russell Investments Group, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2019.